Through comprehensive genomic characterization of genes driving NRF2-dependent cancer cell proliferation, we interrogated the functional interaction between NRF2 and CBP/p300 to uncover a role for this interaction in driving antioxidant capacity. Here, NFE2L2 is linked to cancer.